<unk>  is an alkylating agent that is FDA approved for the treatment of patients with persistent or recurrent ovarian cancer following first-line therapy with a cisplatin and/or alkylating agent-based combination.. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include nausea, vomiting ,Peripheral neuropathy and central nervous system symptoms (mood disorders, disorders of consciousness, ataxia, dizziness, vertigo) and mild to moderate dose-related myelosuppression.
Altretamine
Levocabastine
Orciprenaline
Acrivastine
Theodrenaline
Clemastine
Hexoprenaline
Bepotastine Besilate